Fluid management in critical illness requires a delicate balance between organ perfusion and the prevention of hypervolemia. Although clinicians recognize fluid overload as an independent driver of mortality, contemporary de-resuscitation trials continue to yield conflicting or inconclusive clinical outcomes. A recent systematic review highlights a profound physiological mismatch in critical care literature, termed the ultrasound gap. While bedside ultrasonography has revolutionized modern hemodynamic assessment, interventional studies rarely incorporate these real-time tools to guide fluid evacuation. Consequently, protocols often depend on static numerical balances rather than true physiological tolerance.

The Pathophysiological Burden of Iatrogenic Hypervolemia

During initial shock resuscitation, intravenous fluids restore effective circulating volume and systemic oxygen delivery. However, sustained positive fluid balance progressively leads to pathological interstitial edema, organ dysfunction, and compromised microvascular perfusion. Increased venous pressures directly impair renal filtration gradients, aggravate pulmonary gas exchange, and exacerbate hepatic congestion. Therefore, clinical guidelines emphasize proactive de-escalation once hemodynamic stability is achieved. Clinicians typically administer loop diuretics or initiate continuous renal replacement therapy to achieve negative cumulative fluid balance. Despite widespread implementation of these strategies, observational studies demonstrate persistent iatrogenic injury when volume removal is conducted arbitrarily. Rapid fluid depletion without assessing intravascular filling pressures can provoke secondary hypoperfusion, prerenal acute kidney injury, and refractory hypotension. Thus, effective de-resuscitation necessitates precise physiological monitoring rather than generic fluid restriction targets. Point-of-care ultrasound offers an exceptional modality to evaluate multi-organ venous congestion non-invasively at the bedside. Unfortunately, traditional intensive care protocols have largely relied on crude cumulative intake-output balance sheets. These traditional metrics fail to distinguish pathological intravascular hypervolemia from non-functional third-space edema, leading to erratic therapeutic outcomes.

Evaluating Evidence in Contemporary De-Resuscitation Trials

To characterize the current landscape of volume removal research, investigators conducted a rigorous systematic review of randomized de-resuscitation trials involving critically ill adults. They evaluated thirteen randomized trials encompassing 2,495 patients, assessing methodological quality via the Cochrane Risk of Bias 2 tool. The analysis specifically probed how often objective physiological parameters, particularly ultrasound, informed treatment allocation and weaning protocols. Surprisingly, only four of the thirteen studies incorporated any bedside ultrasound modality. Even more striking, merely one trial explicitly utilized ultrasound assessment to steer the de-resuscitation interventions. However, that isolated trial failed to demonstrate significant fluid separation between the interventional and control arms. Across all thirteen evaluated studies, no trial demonstrated statistically significant reductions in primary hard clinical endpoints, such as all-cause mortality or major organ morbidity. Nevertheless, several investigations successfully satisfied surrogate endpoints. Specifically, 53.8% of the studies achieved distinct fluid balance separation, while others fulfilled feasibility criteria or reduced mechanical ventilation duration. These findings clearly reveal that achieving numerical fluid balance divergence does not automatically guarantee improved patient survival or reduced morbidity.

Unpacking the Ultrasound Gap in Critical Care Research

The systematic review exposes a major translational divide known as the ultrasound gap. Point-of-care ultrasonography has become standard bedside practice across worldwide intensive care units, yet randomized trials continue to neglect its utility. Researchers frequently design clinical trials around arbitrary daily fluid balance goals rather than objective markers of patient congestive state. Consequently, patients receive diuretics or ultrafiltration based solely on time intervals or cumulative charting rather than persistent hemodynamic congestion. This methodology introduces profound clinical heterogeneity into trial cohorts. For example, a patient with severe interstitial lung edema may benefit substantially from aggressive fluid removal. Conversely, a patient with peripheral edema and depleted intravascular volume may suffer acute renal ischemia under identical protocols. Because investigators rarely perform standardized serial echocardiographic or vascular assessments, trials often fail to identify subgroups who benefit from targeted volume extraction. Moreover, the lack of real-time imaging obscures the physiological stopping points of de-resuscitation, increasing the risk of over-diuresis. Bridging this ultrasound gap is therefore paramount to modernizing critical care trial designs and establishing evidence-based resuscitation phases.

Fluid Balance Separation Versus Meaningful Clinical Endpoints

A critical observation emerging from the systematic analysis is the dissociation between achieving fluid separation and modifying clinical outcomes. More than half of the analyzed trials successfully created significant differences in cumulative fluid balances between study arms. Furthermore, select trials reported meaningful improvements in secondary endpoints, including increased ventilator-free days and accelerated extubation times. However, these physiological changes did not translate into reductions in 28-day or 90-day mortality. This discrepancy suggests that fluid balance calculation is a deeply flawed surrogate marker for clinical recovery in critical illness. Daily fluid charts notoriously suffer from inaccurate recording of insensible losses, occult third-spacing, and drain outputs. In addition, forced negative balance in patients without true intravascular congestion can induce occult hemodynamic collapse, offsetting the benefits of pulmonary decongestion. Thus, trial designs must shift focus away from purely mathematical volume calculations. Future investigators must instead validate composite clinical endpoints that reflect resolved organ congestion alongside preserved systemic perfusion. Standardizing these objective endpoints will allow clinical researchers to determine whether active volume depletion truly enhances definitive recovery metrics.

Integrating Dynamic POCUS and VExUS Protocols

To resolve current investigative deficits, future critical care studies must adopt standardized, physiology-driven de-resuscitation algorithms. Combining multi-organ point-of-care ultrasound protocols allows clinicians to comprehensively evaluate cardiac function, pulmonary aeration, and systemic venous congestion. Specifically, lung ultrasound enables rapid quantification of B-lines to monitor resolving pulmonary edema. Concurrently, the Venous Excess Ultrasound score evaluates Doppler waveforms across the inferior vena cava, hepatic veins, portal vein, and intrarenal parenchymal veins. This multi-system approach accurately differentiates intravascular hypervolemia from isolated peripheral edema or capillary leak. In clinical practice, de-resuscitation should initiate when venous congestion is confirmed and cease immediately when Doppler flow pulsatility normalizes or cardiac stroke volume declines. Furthermore, integrating dynamic ultrasound with passive leg raise testing protects patients against unexpected intravascular depletion. When protocols demand objective imaging criteria for both inclusion and titration, researchers can eliminate arbitrary management variability. Ultimately, embedding structured POCUS and Doppler hemodynamics into clinical trials will establish precise physiological boundaries, transforming de-resuscitation from a crude empirical guessing game into an exact, personalized therapeutic science.

What defines the ultrasound gap in clinical de-resuscitation trials?

The ultrasound gap describes the substantial disconnect where point-of-care ultrasound is widely utilized in daily bedside practice but remains largely absent from randomized interventional trials. Although ultrasonography accurately assesses organ venous congestion and pulmonary interstitial fluid, most clinical trials still rely on crude cumulative fluid charting. Consequently, interventional studies fail to apply objective, real-time physiological guidance during active fluid removal phases.

Why does achieving negative fluid balance fail to consistently improve mortality?

Achieving a negative fluid balance does not guarantee improved survival because mathematical fluid charting does not reflect intravascular volume status. If clinicians aggressively remove fluid from patients without true venous congestion, severe intravascular depletion and organ hypoperfusion can develop. Therefore, without real-time physiological monitoring, the adverse effects of hypoperfusion may completely neutralize the benefits of reduced pulmonary or tissue edema.

How can the VExUS protocol improve future de-resuscitation strategies?

The Venous Excess Ultrasound score evaluates systemic venous congestion by examining Doppler waveforms in the inferior vena cava, hepatic, portal, and intrarenal veins. By grading venous congestion severity objectively, VExUS helps clinicians identify exactly when organs suffer from excessive backpressure. Integrating this score into clinical protocols ensures that fluid removal occurs only when congestion is present, avoiding dangerous over-diuresis.

Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Wong A et al. The ultrasound gap in de-resuscitation trials: A systematic review of physiological assessment deficits. Ultrasound J. 2026 Aug 26. doi: 10.5826/tuj.2026.18750. PMID: 42644856.
2. Malbrain MLNG, Martin G, Ostermann M. Everything you need to know about deresuscitation. Intensive Care Med. 2022;48(12):1781-1786.
3. Silversides JA, Major E, Ferguson AJ, et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome: a systematic review and meta-analysis. Intensive Care Med. 2017;43(2):155-170.
4. Beaubien-Souligny W, Rola P, Haycock K, et al. Quantifying systemic congestion with Point-Of-Care ultrasound: development of the venous excess ultrasound score. Ultrasound J. 2020;12(1):16.